Simiso Sokhela to Cost-Benefit Analysis
This is a "connection" page, showing publications Simiso Sokhela has written about Cost-Benefit Analysis.
Connection Strength
0,043
-
Cost and cost-effectiveness of dolutegravir-based antiretroviral regimens: an economic evaluation of a clinical trial. AIDS. 2021 12 15; 35(Suppl 2):S173-S182.
Score: 0,043
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.